Company · CIK 0002012593
Rapport Therapeutics, Inc.
RAPPSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$30.51+$0.66 (+2.21%)
RAPP · Last trade
- Prev close
- $29.85
- Range (30d)
- $29.85 – $44.00
On the record
Recent filings
- 144RAPPRapport Therapeutics, Inc.0001958244-26-000649 · 14.2 KBSEC(opens sec.gov)
- 144RAPPRapport Therapeutics, Inc.0001950047-26-009884 · 4.8 KBSEC(opens sec.gov)
- 144RAPPRapport Therapeutics, Inc.0001950047-26-008670 · 6.4 KBSEC(opens sec.gov)
- 144RAPPRapport Therapeutics, Inc.0001950047-26-008594 · 5.7 KBSEC(opens sec.gov)
- 144RAPPRapport Therapeutics, Inc.0001950047-26-008426 · 4.9 KBSEC(opens sec.gov)
- SCHEDULE 13G/ARAPPRapport Therapeutics, Inc.0001193125-26-352285 · 15.4 KBSEC(opens sec.gov)
- SCHEDULE 13G/ARAPPRapport Therapeutics, Inc.0001172661-26-003693 · 9.6 KBSEC(opens sec.gov)
- SCHEDULE 13G/ARAPPRapport Therapeutics, Inc.0001562230-26-000114 · 7.7 KBSEC(opens sec.gov)
- 10-QRAPPQuarterly update0001193125-26-333862 · 9.8 MBSEC(opens sec.gov)
- 8-KRAPPCurrent report0001193125-26-333853 · 464.5 KBSEC(opens sec.gov)
Insiders
- ARCH Venture Fund XII, L.P.10% Owner
- Bredt DavidChief Scientific Officer
- Burow Kristina10% Owner
- Burrell Terry-AnnDirector
- Ceesay AbrahamDirector, Chief Executive Officer
- CRANDELL KEITH10% Owner
- Galer Bradley S.Chief Medical Officer
- Gault CherylChief Operating Officer
- GILLIS STEVEN10% Owner
- HEALY JAMESDirector
Tickers
Addresses
business
99 HIGH STREET SUITE 2100
BOSTON, MA, 02110
mailing
99 HIGH STREET SUITE 2100
BOSTON, MA, 02110
Former names
- Rapport Therapeutics, Inc.2026-10-08
Same industry